Thrivent Financial for Lutherans
VASC

Thrivent Financial for Lutherans’s Vascular Solutions Inc VASC Stock Holding History

Thrivent Financial for Lutherans’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,430
Closed -$529K – 2068
2016
Q4 		$529K Buy
9,430
+580
+7% +$29.6K ﹤0.01% 1479
2016
Q3 		$427K Buy
8,850
+410
+5% +$19.1K ﹤0.01% 1534
2016
Q2 		$352K Buy
8,440
+440
+6% +$16.4K ﹤0.01% 1584
2016
Q1 		$260K Buy
8,000
+450
+6% +$13K ﹤0.01% 1673
2015
Q4 		$260K Buy
7,550
+400
+6% +$13.6K ﹤0.01% 1648
2015
Q3 		$232K Buy
7,150
+1,050
+17% +$37.6K ﹤0.01% 1555
2015
Q2 		$212K Buy
+6,100
New +$199K ﹤0.01% 1597

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Thrivent Financial for Lutherans's VASC Position: Q1 2017 in Review

Thrivent Financial for Lutherans sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 9,430 shares — an estimated $529K sold.

Thrivent Financial for Lutherans first reported a position in VASC in Q2 2015 and held it in 7 quarters. The position peaked at $529K in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Thrivent Financial for Lutherans reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 9,430 Vascular Solutions Inc shares in Q1 2017, an estimated $529K.
  • Thrivent Financial for Lutherans first reported a position in Vascular Solutions Inc in Q2 2015 and held it in 7 quarters.
  • Thrivent Financial for Lutherans's Vascular Solutions Inc position peaked at $529K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2017, filed 12 May 2017.